Aarti Pharma Labs Share Price Today | Stock Price & Aarti Pharma Labs Share Screener

Track the current stock price of Aarti Pharma Labs with an interactive chart. Analyse AARTIPHARM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aarti Pharma Labs stock quote in one place.

The quote of ₹946.60 sits between the 52-week low of ₹591.95 and the 52-week high of ₹972.80, and the latest session moved -2.26% from the previous close.

Screen Aarti Pharma Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AARTIPHARM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0LRU01027.

Classification

Identifiers and Leadership

Screen AARTIPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹3,482, up from ₹2,906 in 2025.

Latest statistics put total assets at ₹3,482 and shareholder funds at ₹2,125, with a leverage ratio of 0.28.

Screen Aarti Pharma Labs income statement and profit fundamentals. Analyze AARTIPHARM quarterly results. Aarti Pharma Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹544 and net profit was ₹76, equal to earnings per unit of ₹8.40, at an operating margin of 25%.

In that period expenses were ₹400, interest cost ₹13 and tax ₹25. The next period listed, 2026-Mar, shows revenue of ₹596 and net profit of ₹61.

Screen AARTIPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹262, and net cash flow was an inflow of ₹2.

Over the same period, investing activities used ₹431 and financing activities provided ₹171.

See Aarti Pharma Labs shareholding pattern with promoter, FII, and DII holdings. Check Aarti Pharma Labs promoter holding and ownership changes for AARTIPHARM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 42.86%, foreign institutions 8.17%, domestic institutions 7.22% and the public 34.39%, spread across 176,506 shareholders.

The shareholder count was 176,506 in 2026-Jun, compared with 179,373 in 2026-Mar.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aarti Pharma Labs. Aarti Pharma Labs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.50 per unit for 2026-March, a yield of 0.38%, compared with ₹5.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.50, ₹5.00 and ₹3.00 per unit.

See which indices include Aarti Pharma Labs stock. Check AARTIPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Aarti Pharma Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aarti Pharma Labs stock events that may affect AARTIPHARM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 22, 2026, with a record date of September 22, 2026.

It is followed by Dividend dated September 15, 2026 and Quarterly Result Announcement dated August 7, 2026.

Screen AARTIPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen AARTIPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated September 30, 2026 and September 30, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 6 balance sheet periods, 15 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.